CannabisNewsWire
CannabisNewsWire

News and publishing service
for cannabis related companies

LimeLight of The week is

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP)

View The Complete Profile

Lexaria Bioscience Corp. (CSE: LXX) (CSE: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking. 

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hmep-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Investment Considerations

  • Revenue-generating biosciences company focused on improving the delivery of active pharmaceutical ingredients into the bloodstream
  • Proprietary technology shown to enhance the bioavailability of orally ingested cannabinoids while improving the taste
  • Actively developing and selling hemp oil-based consumer products through Lexaria’s brands ViPova™, TurboCBD and ChrgD+
  • Partnership with one of the world’s largest cigarette companies provides up to US$12 million in funding for clinical investigations and product development conducted by Lexaria Nicotine LLC to explore oral forms of nicotine delivery using the Company’s patented DehydraTECH technology
  • One of the world’s largest patent portfolios related to oral delivery of molecules such as cannabinoids, nicotine and more. This patent portfolio reasonably expected to grow even stronger
View More

Receive SMS Text Alerts from CannabisNewsWire

Text "Cannabis" to 21000

(US Mobile Phones Only)

Featured Conference

Cannabis World Congress & Business Expo - Los Angeles, CA - 9/26/19 to 9/28/19

The Cannabis World Congress & Business Exposition is a business-to-business trade show event for the legalized cannabis industry. It is held 3 times per year in the largest media, financial, and business markets: New York, Los Angeles, and Boston. It is the leading forum for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic and fast-growing industry.

Continue


Upcoming Conferences

View All Conferences

About CannabisNewsWire (CNW)

CannabisNewsWire (CNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CNW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CNW is where news, content and information converge.

Stay Informed
We will be posting information about the presenting companies as they take the stage.

See The Latest

Connect With Us
Follow us on social media for the latest news and information from our network of brands and clients.

follow us on twitter meet on linkedin like us on facebook

CannabisNewsWire

CannabisNewsWire
303 S Broadway, Denver, CO 80209 (303) 498-7722


Copyright © 2019. All Rights Reserved.